Drugs Controller General of India's Subject Expert Committee Will Continue a Thorough ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Drugs Controller General of India's subject expert committee will continue a thorough review of data submitted by Serum Institute of India and Bharat Biotech for full market approval to Covaxin and Covishield: Sources'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)